FIELD: medicine, pharmaceutical industry and technology, pharmacy.
SUBSTANCE: invention relates to a composition eliciting an antiviral effect. The composition comprises hydrophilic conglomerate of immunoglobulins consortium adsorbed with polyethylene glycol 4000-6000, recombinant interferon-α2 and a special additive taken among the following substances: glycine, glucose, maltose, sodium chloride taken in the definite ratio of components. Invention provides elevating solubility of composition eliciting an antiviral effect and enhanced release of biologically active substances to solution.
EFFECT: valuable medicinal properties of composition.
5 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION ELICITING ANTIBACTERIAL EFFECT | 2004 |
|
RU2247578C1 |
COMPOSITION POSSESSING ANTIVIRAL AND ANTIBACTERIAL EFFECT | 2006 |
|
RU2292907C1 |
CRYOPROTECTIVE PREPARATION | 2004 |
|
RU2251431C1 |
ANTIVIRAL AND ANTIMICROBIAL ORAL COMPOSITION | 2008 |
|
RU2457856C2 |
CRYOPROTECTIVE OINTMENT | 2004 |
|
RU2251430C1 |
BIOLOGICALLY ACTIVE ADDITION | 2000 |
|
RU2164765C1 |
ANTIVIRAL AND ANTIMICROBIAL COMPOSITION | 2008 |
|
RU2457857C2 |
ANTIVIRAL AND ANTIMICROBIAL COMPOSITION | 2008 |
|
RU2457855C2 |
ANTIVIRAL AND ANTIMICROBIAL COMPOSITION CONTAINING CONSORTIUM OF IMMUNOGLOBULINS | 2008 |
|
RU2457861C2 |
ANTIVIRAL AND ANTIMICROBIAL COMPOSITION CONTAINING CONSORTIUM OF IMMUNOGLOBULINS | 2008 |
|
RU2457863C2 |
Authors
Dates
2005-03-10—Published
2004-04-27—Filed